Clinical Trial Update: Efficacy and Safety of Orally Administered BBT-401-1S in Subjects With Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting efficacy and safety of orally administered BBT-401-1S in subjects with Ulcerative Colitis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• BBT-401-1S

Snippet

Sponsor: Bridge Biotherapeutics, Inc. | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED | Results posted: 2023-09-07